Inventor · disambiguated record
Bert Klebl
Also filed as: KLEBL BERT
8 granted patents·16 pending applications·96 citations·filing 2003–2023
82Inventor score
Files withLEAD DISCOVERY CENTER GMBH6GPC BIOTECH AG4CHOIDAS AXEL3SANOFI AVENTIS DEUTSCHLAND2AVENTIS PHARMA GMBH1
Top patents by PatentIndex Score
24 records- 0188US8084457B2Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinasesCHOIDAS AXEL·Filed 2004·Granted Dec 27, 2011·76 cites·25 claims
- 0279US8999982B2Pharmaceutically active compounds as Axl inhibitorsSCHULTZ-FADEMRECHT CARSTEN·Filed 2011·Granted Apr 7, 2015·10 cites·15 claims
- 0374US9242937B2Pharmaceutically active disubstituted pyridine derivativesRÜHTER GERD·Filed 2012·Granted Jan 26, 2016·5 cites·7 claims
- 0473US8507498B24, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinasesWABNITZ PHILIPP·Filed 2008·Granted Aug 13, 2013·4 cites·24 claims
- 0560US2025205242A1Cdk7 inhibitors for antiviral treatmentQURIENT CO LTD·Filed 2023·Application pending·0 cites
- 0658US2024294522A13-substituted 1h-pyrrolo[2,3-b]pyridine as grk5 modulatorsLEAD DISCOVERY CENTER GMBH·Filed 2022·Application pending·0 cites
- 0754US2024415819A1Macrocyclic compounds as proteasome subunit beta type-5 inhibitorsLEAD DISCOVERY CENTER GMBH·Filed 2022·Application pending·0 cites
- 0852US2024252454A1Composition comprising an inhibitor of mitochondrial transcriptionLEAD DISCOVERY CENTER GMBH·Filed 2022·Application pending·0 cites
- 0949US7341717B2Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful thereforGPC BIOTECH AG·Filed 2003·Granted Mar 11, 2008·1 cites·10 claims
- 1048US2006151574A1Formulations useful against hepatitis C virus infectionsGPC BIOTECH AG·Filed 2003·Application pending·0 cites
- 1147US2008213798A1Novel c. elegans p21-activated kinase (pak) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of pak activity in the nematode, caenorhabditis elegansSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Application pending·0 cites
- 1245US11111238B2Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancerLEAD DISCOVERY CENTER GMBH·Filed 2018·Granted Sep 7, 2021·0 cites·20 claims
- 1344US10703735B24-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancerLEAD DISCOVERY CENTER GMBH·Filed 2019·Granted Jul 7, 2020·0 cites·14 claims
- 1444US2022370440A14-substituted pyrrolo[2,3-b]pyridine as erbb modulators useful for treating cancerLEAD DISCOVERY CENTER GMBH·Filed 2019·Application pending·0 cites
- 1543US2013338147A14,6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinasesINGENIUM PHARMACEUTICALS GMBH·Filed 2013·Application pending·0 cites
- 1642US7319024B1C. elegans p21-activated kinase (PAK) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of PAK activity in the nematode, caenorhabditis elegansSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Jan 15, 2008·0 cites·7 claims
- 1739US2014287454A1Susceptibility to selective cdk9 inhibitorsCHOIDAS AXEL·Filed 2012·Application pending·0 cites
- 1839US2004143854A1Method for generating a genetically modified organismAVENTIS PHARMA GMBH·Filed 2003·Application pending·0 cites
- 1938US2008207677A1Napthyridine Compounds As Rock InhibitorsGPC BIOTECH AG·Filed 2006·Application pending·0 cites
- 2037US2007275962A1Heterobicyclic Compounds as Pharmaceutically Active AgentsGPC BIOTECH AG·Filed 2004·Application pending·0 cites
- 2137US2006105445A1Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteinsGODL KLAUS·Filed 2003·Application pending·0 cites
- 2236US2008187575A1Pyrimidine DerivativesKLEBL BERT·Filed 2005·Application pending·0 cites
- 2336US2013079345A1Pharmaceutically active disubstituted triazine derivativesEICKHOFF JAN·Filed 2011·Application pending·0 cites
- 2433US2015329537A2Cdk9 inhibitors in the treatment of midline carcinomaCHOIDAS AXEL·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bert Klebl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →